iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Baldwin Investment Management LLC

Baldwin Investment Management LLC lowered its stake in iShares Biotechnology ETF (NASDAQ:IBBFree Report) by 8.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,480 shares of the financial services provider’s stock after selling 225 shares during the period. Baldwin Investment Management LLC’s holdings in iShares Biotechnology ETF were worth $337,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently modified their holdings of IBB. First Horizon Advisors Inc. increased its position in shares of iShares Biotechnology ETF by 5.5% in the fourth quarter. First Horizon Advisors Inc. now owns 2,193 shares of the financial services provider’s stock worth $298,000 after acquiring an additional 115 shares in the last quarter. Pinnacle Wealth Management Advisory Group LLC raised its holdings in shares of iShares Biotechnology ETF by 8.3% during the fourth quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,931 shares of the financial services provider’s stock worth $262,000 after acquiring an additional 148 shares in the last quarter. Corient Private Wealth LLC boosted its position in iShares Biotechnology ETF by 1.0% during the fourth quarter. Corient Private Wealth LLC now owns 86,700 shares of the financial services provider’s stock valued at $11,778,000 after purchasing an additional 841 shares during the last quarter. Great Valley Advisor Group Inc. grew its stake in iShares Biotechnology ETF by 14.1% in the fourth quarter. Great Valley Advisor Group Inc. now owns 2,786 shares of the financial services provider’s stock valued at $378,000 after purchasing an additional 344 shares in the last quarter. Finally, Premier Path Wealth Partners LLC acquired a new position in iShares Biotechnology ETF in the 4th quarter worth about $207,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.6 %

Shares of iShares Biotechnology ETF stock opened at $136.72 on Friday. The stock has a 50-day simple moving average of $132.51 and a 200-day simple moving average of $133.05. iShares Biotechnology ETF has a 52-week low of $111.83 and a 52-week high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were paid a $0.126 dividend. This represents a $0.50 dividend on an annualized basis and a yield of 0.37%. The ex-dividend date was Thursday, March 21st.

iShares Biotechnology ETF Profile

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Recommended Stories

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBBFree Report).

Institutional Ownership by Quarter for iShares Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.